dbo:abstract |
Funktionelle Selektivität bezeichnet in der Pharmakologie das Phänomen, dass biologisch wirksame Substanzen (Wirkstoffe, Liganden) nach deren Bindung an einen Rezeptor bevorzugt einen von mehreren möglichen Signaltransduktionswegen aktivieren können. Dieses Phänomen kann prinzipiell an allen Rezeptoren beobachtet werden, die mindestens zwei verschiedene Signaltransduktionswege gekoppelt sind. Funktionelle Selektivität konnte für verschiedene Liganden an und G-Protein-gekoppelten Rezeptoren beobachtet werden. Die Beobachtung einer funktionellen Selektivität eines Liganden kann dabei kausal auf die Unterschiedlichkeit der untersuchten Effekte (z. B. schnell oder langsam einsetzende Effekte), unterschiedlich starke Expression und Aktivität des Rezeptorproteins oder auf Eigenschaften des Liganden selbst zurückgeführt werden. Im letzteren Fall spricht man auch von biased agonism, agonist-selective trafficking of stimulus oder ligand-selective agonism. (de) Functional selectivity (or “agonist trafficking”, “biased agonism”, “biased signaling”, "ligand bias" and “differential engagement”) is the ligand-dependent selectivity for certain signal transduction pathways relative to a reference ligand (often the endogenous hormone or peptide) at the same receptor. Functional selectivity can be present when a receptor has several possible signal transduction pathways. To which degree each pathway is activated thus depends on which ligand binds to the receptor. Functional selectivity, or biased signaling, is most extensively characterized at G protein coupled receptors (GPCRs). A number of biased agonists, such as those at muscarinic M2 receptors tested as analgesics or antiproliferative drugs, or those at opioid receptors that mediate pain, show potential at various receptor families to increase beneficial properties while reducing side effects. For example, pre-clinical studies with G protein biased agonists at the μ-opioid receptor show equivalent efficacy for treating pain with reduced risk for addictive potential and respiratory depression. Studies within the chemokine receptor system also suggest that GPCR biased agonism is physiologically relevant. For example, a beta-arrestin biased agonist of the chemokine receptor CXCR3 induced greater chemotaxis of T cells relative to a G protein biased agonist. (en) |
dbo:wikiPageExternalLink |
https://cdr.lib.unc.edu/record/uuid:e3546176-4b38-4c42-bfec-8990d429363f |
dbo:wikiPageID |
1811292 (xsd:integer) |
dbo:wikiPageLength |
16815 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1097529812 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Epiphenomenon dbr:Lisuride dbr:Pharmacology dbr:Ligand_(biochemistry) dbr:Psychedelic_drug dbc:Neurophysiology dbr:Gene_expression dbr:Second_messenger_system dbr:Phospholipase_A2 dbr:Monoamine_oxidase_inhibitor dbr:Arachidonic_acid dbr:Lysergic_acid_diethylamide dbr:Receptor_antagonist dbr:Phospholipase_C dbr:2,5-Dimethoxy-4-bromoamphetamine dbc:Biased_ligands dbc:Pharmacodynamics dbr:Tianeptine dbr:G_protein dbr:Agonist dbr:Analgesia dbr:5-HT2A_receptor dbr:5-HT2C_receptor dbr:5-HT_receptor dbr:Cytochrome_P450_reductase dbr:Delta_opioid_receptor dbr:Protein_dimer dbr:Receptor_(biochemistry) dbr:Atypical_antidepressant dbr:Inverse_agonist dbr:Μ-opioid_receptor dbc:Signal_transduction dbr:Effector_(biology) dbr:Heteromer dbr:Signal_transduction dbr:Dimethyltryptamine dbr:CXCR3 dbr:Oliceridine dbr:Selective_serotonin_reuptake_inhibitor dbr:Serotonin dbr:SNC80 dbr:G_protein_coupled_receptors dbr:Mixed_agonist-antagonist dbr:Respiratory_depression dbr:Receptor_internalization dbr:Inositol_triphosphate dbr:Postulate dbr:ARM390 |
dbp:wikiPageUsesTemplate |
dbt:Cite_book dbt:Cite_journal dbt:Distinguish dbt:More_footnotes dbt:Refbegin dbt:Refend dbt:Reflist dbt:Abbrlink dbt:Pharmacology |
dct:subject |
dbc:Neurophysiology dbc:Biased_ligands dbc:Pharmacodynamics dbc:Signal_transduction |
rdf:type |
owl:Thing |
rdfs:comment |
Funktionelle Selektivität bezeichnet in der Pharmakologie das Phänomen, dass biologisch wirksame Substanzen (Wirkstoffe, Liganden) nach deren Bindung an einen Rezeptor bevorzugt einen von mehreren möglichen Signaltransduktionswegen aktivieren können. Dieses Phänomen kann prinzipiell an allen Rezeptoren beobachtet werden, die mindestens zwei verschiedene Signaltransduktionswege gekoppelt sind. Funktionelle Selektivität konnte für verschiedene Liganden an und G-Protein-gekoppelten Rezeptoren beobachtet werden. (de) Functional selectivity (or “agonist trafficking”, “biased agonism”, “biased signaling”, "ligand bias" and “differential engagement”) is the ligand-dependent selectivity for certain signal transduction pathways relative to a reference ligand (often the endogenous hormone or peptide) at the same receptor. Functional selectivity can be present when a receptor has several possible signal transduction pathways. To which degree each pathway is activated thus depends on which ligand binds to the receptor. Functional selectivity, or biased signaling, is most extensively characterized at G protein coupled receptors (GPCRs). A number of biased agonists, such as those at muscarinic M2 receptors tested as analgesics or antiproliferative drugs, or those at opioid receptors that mediate pain, show poten (en) |
rdfs:label |
Funktionelle Selektivität (de) Functional selectivity (en) |
owl:differentFrom |
dbr:Binding_selectivity |
owl:sameAs |
freebase:Functional selectivity yago-res:Functional selectivity wikidata:Functional selectivity dbpedia-de:Functional selectivity dbpedia-sh:Functional selectivity dbpedia-sr:Functional selectivity https://global.dbpedia.org/id/HKn1 |
prov:wasDerivedFrom |
wikipedia-en:Functional_selectivity?oldid=1097529812&ns=0 |
foaf:isPrimaryTopicOf |
wikipedia-en:Functional_selectivity |
is dbo:wikiPageDisambiguates of |
dbr:Selectivity |
is dbo:wikiPageRedirects of |
dbr:Nonselective dbr:Biased_agonism dbr:Functional_Selectivity dbr:Drug_selectivity dbr:Biased_agonist dbr:Functionally_selective dbr:Ligand_bias dbr:Selectivity_(biochemistry) |
is dbo:wikiPageWikiLink of |
dbr:Psilocin dbr:Salvinorin dbr:Salvinorin_A dbr:Metalloprotease_inhibitor dbr:Nonselective dbr:Biased_agonism dbr:List_of_opioids dbr:Lisuride dbr:Renin_inhibitor dbr:DCW234 dbr:Dopamine_receptor_D1 dbr:Dopaminergic dbr:ERA-45 dbr:ORG-37684 dbr:Protease-activated_receptor_2 dbr:Phosphodiesterase_3 dbr:S-40503 dbr:SKF-81,297 dbr:SN-22 dbr:Erteberel dbr:Cipralisant dbr:Mitragyna_speciosa dbr:Mitragynine_pseudoindoxyl dbr:Lysergic_acid_diethylamide dbr:MTEP dbr:Functional_Selectivity dbr:Functional_agonist dbr:2-Methyl-5-hydroxytryptamine dbr:BIMU8 dbr:BMS-564,929 dbr:Bamifylline dbr:Bromocriptine dbr:Brorphine dbr:CGS-12066A dbr:CPD-1 dbr:Tiospirone dbr:WAY-204688 dbr:Drug_delivery dbr:Drug_interaction dbr:GRK5 dbr:GRK6 dbr:G_protein-coupled_receptor dbr:G_protein-coupled_receptor_kinase_2 dbr:G_protein-coupled_receptor_kinase_3 dbr:3,4-Methylenedioxyphenethylamine dbr:4-Methylamphetamine dbr:5-Carboxamidotryptamine dbr:6'-Guanidinonaltrindole dbr:6-Nitroquipazine dbr:Agonist dbr:Anabolic_steroid dbr:5-HT2A_receptor dbr:5-HT2C_receptor_agonist dbr:5-HT7_receptor dbr:DBL-583 dbr:DOx dbr:Ergotamine dbr:F-15,599 dbr:Fenobam dbr:Flupentixol dbr:Osemozotan dbr:Oxaprotiline dbr:PF-04479745 dbr:PF-219,061 dbr:PF-592,379 dbr:Discovery_and_development_of_HIV-protease_inhibitors dbr:Discovery_and_development_of_nucleosid...tide_reverse-transcriptase_inhibitors dbr:Histamine_H3_receptor dbr:Iproclozide dbr:Μ-opioid_receptor dbr:Aripiprazole dbr:LGD-3303 dbr:LY-266,097 dbr:Binding_selectivity dbr:Trevena_Inc dbr:Igor_V._Komarov dbr:Metfendrazine dbr:ORG-12962 dbr:Opioid dbr:Cannabinoid_receptor_type_2 dbr:Quinpirole dbr:RB-64 dbr:RU-24,969 dbr:Ramelteon dbr:Selective_serotonin_reuptake_inhibitor dbr:Setastine dbr:Yessotoxin dbr:Selectivity dbr:Neurolixis dbr:Κ-opioid_receptor dbr:NK1_receptor_antagonist dbr:Trimethylenemethane_cycloaddition dbr:PZM21 dbr:SERBA-2 dbr:Drug_selectivity dbr:Biased_agonist dbr:Functionally_selective dbr:Ligand_bias dbr:Selectivity_(biochemistry) |
is foaf:primaryTopic of |
wikipedia-en:Functional_selectivity |